COSCIENS Biopharma Inc
TSX:CSCI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
COSCIENS Biopharma Inc
TSX:CSCI
|
CA |
|
Univastu India Ltd
NSE:UNIVASTU
|
IN |
|
Quixant PLC
LSE:QXT
|
UK |
|
S
|
Sociedad Comercial del Plata SA
SIX:CADN
|
AR |
|
M
|
MITCON Consultancy & Engineering Services Ltd
NSE:MITCON
|
IN |
|
Focus Entertainment SA
F:0HF
|
FR |
|
E
|
ESR Cayman Ltd
HKEX:1821
|
HK |
|
Alexandria Group Oyj
F:3ZL
|
FI |
|
U
|
Uniparts India Ltd
NSE:UNIPARTS
|
IN |
|
G
|
Gamehaus Holdings Inc
NASDAQ:GMHS
|
CN |
|
Most Kwai Chung Ltd
HKEX:1716
|
HK |
|
HK Electric Investments Ltd
HKEX:2638
|
HK |
|
Aeon Financial Service Co Ltd
TSE:8570
|
JP |
|
SPoT Coffee (Canada) Ltd
XTSX:SPP
|
CA |
|
J
|
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
|
CN |
|
G
|
GRP Ltd
SGX:BLU
|
SG |
|
Orbia Advance Corporation SAB de CV
BMV:ORBIA
|
MX |
|
Aeris Environmental Ltd
ASX:AEI
|
AU |
|
Bonava AB (publ)
STO:BONAV B
|
SE |
COSCIENS Biopharma Inc
COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
